If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
Auxilium to Host Teleconference and Webcast on Wednesday, February 3 at 8:30 a.m. Eastern Time MALVERN, PA, Feb TWO –(HSMN NewsFeed) - Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL ), a specialty biopharmaceutical company, today announced that it has rece…
Biopharmaceuticals, FDA
Auxilium Pharmaceuticals, XIAFLEX, Dupuytren’s contracture
Posts on ‘February 2nd, 2010’
Auxilium Announces U.S. Food and Drug Administration Approval for XIAFLEX(TM) for the Treatment of Dupuytren’s Contracture
2 Studies Discover Artefill(R) to Be a Long-Term Treatment Option for Facial Lipoatrophy
Investigator-Initiated Studies Examine Artefill’s Use with Age-Related and HIV-Associated Facial Lipoatrophy Patients SAN DIEGO, Feb. 2 (HSMN NewsFeed) — Suneva Medical, a privately-held aesthetic clinical device company, today announced that two clin…
Devices, Dermatology
Suneva Clinical, Artefill, lipoatrophy
Sensors for Medicine and Science, Inc. Names Dr. Paul Strumph as Chief Medical Officer
GERMANTOWN, Md., Feb. 2 (HSMN NewsFeed) — Sensors for Medicine and Science, Inc., a clinical-stage, pharma device company pioneering breakthrough technology that could dramatically improve glucose monitoring for people with diabetes, today announced th…
Devices, Monitoring, Endocrinology, Personnel
Sensors for Medicine and Science, implanted continuous glucose monitor
Bio-Matrix Scientific Group’s Majority Owned Subsidiary Entest BioMedical Initiates Studies to Support Stem Cell / Laser Regenerative Therapy for COPD
Every 4 Minutes an American Dies of COPD 24 Million Americans Have COPD and 12 Million Don’t Know It $170 Billion over the Next 5 Years Will Be Spent Treating COPD SAN DIEGO, CA - (HSMN NewsFeed) - Bio-Matrix Scientific Group Inc. (OTC.BB:BMSN ) a…
Regenerative Medicine
Bio-Matrix Scientific Group, Entest BioMedical, stem cell, COPD
STAAR Surgical’s Visian(R) ICL(TM) is First Phakic Lens to Be Approved in Japan
MONROVIA, Calif., Feb. 2 (HSMN NewsFeed) — STAAR Surgical Company (Nasdaq: STAA), a big developer, manufacturer and marketer of minimally invasive ophthalmic products, announced today regulatory approval from the Japanese Ministry of Health, Labor a…
Devices, Ophthalmology, Regulatory
STAAR Surgical, Visian, Implantable Collamer Lens, myopia
